PR
    Pharmacy Remedy

    Hepatitis C Treatment in Azerbaijan 2026 — Harvoni, Epclusa, Mavyret

    Direct-acting antivirals (DAAs) for all HCV genotypes — 8-12 week cure regimens supplied to Baku and 9 cities.

    📱 WhatsApp Consultation

    Pharmacy Remedy supplies the modern HCV cure regimens to Azerbaijan: Harvoni (ledipasvir/sofosbuvir), Epclusa (sofosbuvir/velpatasvir) pan-genotypic, and Mavyret (glecaprevir/pibrentasvir) 8-week pan-genotypic. Cure rates exceed 95% with proper genotype-matched regimen.

    Standard Cure Regimens

    • Genotype 1 treatment-naive no cirrhosis: Harvoni 1 tab daily × 8-12 weeks
    • Pan-genotypic (any GT) no cirrhosis: Mavyret 3 tabs daily × 8 weeks
    • Pan-genotypic with compensated cirrhosis: Epclusa 1 tab daily × 12 weeks
    • DAA-failure retreatment: Vosevi 1 tab daily × 12 weeks

    Other conditions

    Lung CancerBreast CancerMelanomaMultiple Myeloma